You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IL-2 pathway agonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

Not yet recruiting
  • Head and Neck Neoplasms
  • TransCon TLR7/8 Agonist
  • +2 more
  • (no location specified)
Aug 4, 2023

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • TransCon IL-2 β/γ
  • +4 more
  • Boston, Massachusetts
  • +7 more
Nov 16, 2022

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 30, 2022

Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255

Recruiting
  • Non-Hodgkin Lymphoma
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • NKTR-255 at 1.5 µg/kg
  • +3 more
  • La Jolla, California
  • +26 more
Jan 10, 2023

Prostate Cancer Trial (iMAB, cMAB)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Jul 26, 2023

Autoimmune Diseases, Inflammatory Disease, Acquired Bone Marrow Aplasia Trial (Blood sample taken at a single time point)

Not yet recruiting
  • Autoimmune Diseases
  • +10 more
  • Blood sample taken at a single time point
  • (no location specified)
Sep 14, 2022

Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

Completed
  • Acute Myelogenous Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 4, 2023

HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

Not yet recruiting
  • HIV Infections
  • sD-NP-GT8 DNA
  • +4 more
  • Birmingham, Alabama
  • +5 more
Mar 10, 2023

COPD Trial in Worldwide (Itepekimab (SAR440340), Placebo, Any Inhaled Corticosteroids as prescribed by treating physician as

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Los Angeles, California
  • +82 more
Oct 28, 2022

Multiple Sclerosis Trial in Rennes (Blood sampling, CSF sampling)

Recruiting
  • Multiple Sclerosis
  • Blood sampling
  • CSF sampling
  • Rennes, France
    CHU Rennes
Apr 26, 2022

Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Asthma in Children Trial (Bi-level Positive Airway Pressure, Sham Bi-level Positive Airway Pressure)

Not yet recruiting
  • Asthma in Children
  • Bi-level Positive Airway Pressure
  • Sham Bi-level Positive Airway Pressure
  • (no location specified)
Apr 27, 2023

Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

Recruiting
  • Neuroblastoma Recurrent
  • Natural killer cell
  • +4 more
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Feb 22, 2023

TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid

Not yet recruiting
  • TIA
  • +2 more
  • Interleukin-2 [IL-2]
  • Standard care - Carotid Endarterectomy
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrookes Hospital
Aug 2, 2023

PGE2/IL-22 Pathway in Various Forms of Eczema

Unknown status
  • Eczema
  • Aspirin 300mg
  • (no location specified)
Oct 18, 2019

Periodontitis, Diabetes, Type 2 Trial in Istanbul (Non-Surgical Periodontal Treatment)

Completed
  • Periodontitis
  • Diabetes Mellitus, Type 2
  • Non-Surgical Periodontal Treatment
  • Istanbul, Turkey
    Marmara University
Nov 11, 2023

PM2.5 Exposure and Ferroptosis in Seizures Patients

Active, not recruiting
  • Exposure to Polluted Air
    • Wuxi, Jiangsu, China
      Affiliated Hospital of JiangNan University, Department of Pediat
    Mar 5, 2023

    Pulmonary Fibrosis, Tumor Trial in Randwick (9MW3811 injection, Placebo)

    Not yet recruiting
    • Pulmonary Fibrosis
    • Tumor
    • 9MW3811 injection
    • Placebo
    • Randwick, New South Wales, Australia
      Scientia Clinical Research
    Feb 13, 2023

    HIV/AIDS Trial in Bangkok (N-803)

    Recruiting
    • HIV/AIDS
    • Bangkok, Thailand
      Thai Red Cross AIDS Research Centre
    Oct 4, 2021

    Breast Cancer Recurrent Trial in Worldwide (Palbociclib 125mg, Standard endocrine therapy)

    Recruiting
    • Breast Cancer Recurrent
    • Palbociclib 125mg
    • Standard endocrine therapy
    • Graz, Austria
    • +52 more
    Nov 15, 2022

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Metastatic Renal Cell Carcinoma
    • bempegaldesleukin
    • +3 more
    • Anchorage, Alaska
    • +108 more
    Mar 31, 2022

    Skin Restricted Lupus, Psychiatric Disorders Trial in Clermont-Ferrand (Biological dosage from plasma)

    Completed
    • Skin Restricted Lupus
    • Psychiatric Disorders
    • Biological dosage from plasma
    • Clermont-Ferrand, France
      CHU Clermont-Ferrand
    Jan 5, 2023

    IL13 Signaling in Allergic Asthma

    Not yet recruiting
    • Asthma, Allergic
    • +2 more
      • Durham, North Carolina
        Duke Asthma Allergy and Airway Center
      Jul 26, 2022

      Homologous Recombination Repair Pathway Gene Mutation Spectrum

      Not yet recruiting
      • Breast Cancer
        • (no location specified)
        Jun 4, 2023

        Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

        Not yet recruiting
        • Pericarditis
        • IL1RA Antibody Assay
        • suPAR Testing
        • Homburg, Germany
        • +8 more
        Jun 22, 2023